Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study

BACKGROUND: The evidence of radiofrequency ablation (RFA) following transarterial chemoembolisation (TACE) combined with sorafenib for intermediate-stage recurrent hepatocellular carcinoma (RHCC) is limited. Patient responses to this treatment vary because of the heterogeneous nature of RHCC, making...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Hui, Duan, Wen-Bin, Liang, Wei, Li, Hui, Xie, Xiao-Yan, Li, Shao-Qiang, Chen, Min-Shan, Liang, Ping, Mao, Xian-Hai, Zhou, Qun-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871741/
https://www.ncbi.nlm.nih.gov/pubmed/36703645
http://dx.doi.org/10.1016/j.eclinm.2022.101816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871741/
https://www.ncbi.nlm.nih.gov/pubmed/36703645
http://dx.doi.org/10.1016/j.eclinm.2022.101816

Ejemplares similares